Medicaid Provider Alert: Provider revalidation has begun and those not completing the process risk disenrollment. Check your account now to learn when your revalidation is due. More information here.

Drugs and Therapeutics (D & T) Committee Meeting Results for: March 18, 2015

Drug Name	Review Type	Committee Recommendation	Prior Approval Status � Final Determination
Viekira Pak	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Zontivity	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Harvoni	New Drug Initial Review	Add to Preferred Status	Preferred and Require Prior Approval
Savaysa	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Grastek	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Ragwitek	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Plegridy	New Drug Initial Review	Require Prior Approval	Prior Approval Required
Orbactiv	New Drug Initial Review	Remove Prior Approval Requirement	Prior Approval Required

Footer